The Herald was informed last week of a 15-year-old special-needs Chaparral High School student who is in need of a kidney ...

J.P. Morgan’s U.S. equity analysts picked their top stocks for 2025 in healthcare, selecting “the most compelling investment ...

The acquisition combines the assets and capabilities of two companies founded by a leader in the GPR68 field, Professor Darren Kelly, consolidating a pipeline that now includes two Phase 2 and one ...

Pegtibatinase is a recombinant enzyme commercialized by Travere Therapeutics, with a leading Phase III program in Homocystinuria.

Rilzabrutinib is a small molecule commercialized by Sanofi, with a leading Phase III program in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura).